Manolo Bellotto
Corporate Officer/Principal bij GAIN THERAPEUTICS, INC.
Oorsprong van het eerstegraads netwerk van Manolo Bellotto
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 17 | |
| Public Company | Medical Distributors | 5 | |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Manolo Bellotto via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chairman Director/Board Member Founder Corporate Officer/Principal | |
| GENTIUM S.P.A. (ADR) | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| ADMA BIOLOGICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| MOLMED S.P.A. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| NEUBASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| THERIVA BIOLOGICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
Elion Oncology, Inc.
 Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Elion Oncology, Inc. engages in the provision of pharmaceutical services. The company was founded in 2016 and is headquartered in Bethesda, MD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Bocconi | College/University | Undergraduate Degree Graduate Degree | |
| University of Barcelona | College/University | Doctorate Degree Doctorate Degree | |
ADMA Plasma Biologics, Inc.
 ADMA Plasma Biologics, Inc. BiotechnologyHealth Technology ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ. | Biotechnology | Director/Board Member Director/Board Member | |
| Life Sciences Management GmbH | Chief Executive Officer | ||
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
| Arpida, Inc. | Chairman | ||
| Marion Merrell Dow (Europe) AG | Corporate Officer/Principal | ||
| Chelsea College | College/University | Undergraduate Degree | |
| Imperial College London | College/University | Doctorate Degree | |
Hoechst Marion Roussel Group
 Hoechst Marion Roussel Group BiotechnologyHealth Technology Part of Sanofi, Hoechst Marion Roussel Group designs molecule inhibitors. The company is based in Frankfurt, Germany. | Biotechnology | Corporate Officer/Principal | |
| FENNEC PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman | |
Sirius Healthcare Partners GmbH
 Sirius Healthcare Partners GmbH Investment ManagersFinance Sirius Healthcare Partners GmbH provides independent advice to small and mid-cap healthcare companies, venture capital firms, institutional and private investors. The firm's services include strategic advisory, mergers and acquisition and financing advisory. It serves in the area of biotechnology, medical technology and diagnostics, platform technologies and healthcare markets. The company was founded by Subhasis Roy, Khalid Islam, Ernesto Mancosu, Werner Tschollar, Andreas Vogler and Mikael von Euw and is headquartered in Zurich, Switzerland. | Investment Managers | Founder | |
Kurma Biofund FCPR
 Kurma Biofund FCPR Investment ManagersFinance Kurma Biofund seeks investment opportunities in life science and biotechnology companies located in Europe. The investments are done in cooperation with medical institutes and universities such as Institut Pasteur and Institut Curie. Its investment size ranges between €0.10 and €6 million. | Investment Managers | Corporate Officer/Principal | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member | |
Prev AbR LLC
 Prev AbR LLC BiotechnologyHealth Technology Prev AbR LLC develops biologic and beta-lactamase compounds. The private company is based in Bethesda, MD. The company was founded by Khalid Islam. | Biotechnology | Founder | |
UCSD Medical Center
 UCSD Medical Center Medical/Nursing ServicesHealth Services UCSD Medical Center provides medical services to its clients. The medical center is a part of University of California, San Diego. UCSD Medical Center's facilities consist of UCSD Thornton Hospital in La Jolla, UCSD Medical Center in Hillcrest, and several specialty outpatient clinics and ambulatory health facilities throughout the area. The services provided by the medical center and its affiliates include general medicine and primary care, women's health services, and emergency care for the treatment of serious conditions. The company is headquartered in San Diego, CA | Medical/Nursing Services | Corporate Officer/Principal | |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Public Communications Contact | |
| Adenium AB | Chairman | ||
| University of Milan | College/University | Corporate Officer/Principal | |
Rheoscience A/S
 Rheoscience A/S Pharmaceuticals: MajorHealth Technology Rheoscience A/S develops and manufactures pharmaceutical products. The private company is based in Redovre, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member | |
| PROCESSA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
TiVenture SA
 TiVenture SA Investment ManagersFinance TiVenture SA is a venture capital fund with headquarters in Lugano, Switzerland. The firm was founded in 2012. | Investment Managers | Private Equity Investor | |
| BioAim LLC | Founder | ||
Caerus Consulting AS
 Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Pharmaceuticals: Major | Chairman | |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Ferring Holding SA
 Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Hph Management GmbH
 Hph Management GmbH Miscellaneous Commercial ServicesCommercial Services Hph Management GmbH provides business consulting services. The private company is based in Küssnacht, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Medical Imaging Analysis Center | Chairman | ||
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Sales & Marketing | |
Aop Orphan Pharmaceuticals GmbH
 Aop Orphan Pharmaceuticals GmbH BiotechnologyHealth Technology Aop Orphan Pharmaceuticals GmbH researches, develops, produces, and distributes drugs. It provides individual treatments for HematoOncology; Cardiology and Pulmonology; and Neurology and Metabolic Disorders. The company was founded by Rudolf S. Widmann in 1996 and is headquartered in Vienna, Austria. | Biotechnology | Director/Board Member | |
| DR. REDDY'S LABORATORIES LIMITED | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 17 |
| Zwitserland | 12 |
| Italië | 5 |
| Denemarken | 4 |
| Zweden | 4 |
Sectoraal
| Health Technology | 33 |
| Consumer Services | 6 |
| Finance | 5 |
| Health Services | 2 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 160 |
| Corporate Officer/Principal | 53 |
| Independent Dir/Board Member | 44 |
| Chairman | 31 |
| Chief Executive Officer | 27 |
Sterkste connecties
| Insiders | |
|---|---|
| Robert Peugeot | 43 |
| Khalid Islam | 29 |
| Dov Goldstein | 28 |
| Hans-Peter Hasler | 28 |
| Eric Richman | 21 |
| Gwen Melincoff | 20 |
| Matthias Alder | 18 |
| Claude Nicaise | 16 |
| Roberto de Ponti | 16 |
| Somboon Prasitjutrakul | 15 |
| Charles Ballantyne | 15 |
| Roberto Barzi | 14 |
| Jeffrey Riley | 13 |
| Rainer-Marc Frey | 11 |
| Lorenzo Leoni | 9 |
- Beurs
- Insiders
- Manolo Bellotto
- Bedrijfsconnecties
